Based on SEC filing data. A Seattle-based biotech corporation in the seed stage has raised $445,000 in equity funding.
Get notified the moment Stemgenics, Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.